This inventor holds 1 USPTO granted patent. Top assignee: Cytel Corporation. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Horacio Serra: Innovator in Ex Vivo Therapy
Introduction
Horacio Serra is a notable inventor based in San Diego, CA. He has made significant contributions to the field of immunotherapy, particularly through his innovative methods for activating cytotoxic T lymphocytes (CTL). His work is pivotal in advancing therapeutic techniques that harness the body's immune response.
Latest Patents
Horacio Serra holds a patent titled "Methods for ex vivo therapy using peptide-loaded antigen presenting." This patent outlines methods for activating CTL in vitro, which are then utilized for therapy in vivo. Additionally, it presents a method for selectively killing specific CTL in vivo using antigen presenting cells that have been modified in vitro. This innovative approach has the potential to enhance the effectiveness of immunotherapies.
Career Highlights
Horacio Serra is associated with Cytel Corporation, a company known for its advancements in biostatistics and clinical trial design. His work at Cytel has allowed him to collaborate with leading experts in the field, furthering the development of cutting-edge therapies.
Collaborations
Some of his notable coworkers include Esteban Celis and Ralph T Kubo. Their collective expertise contributes to the innovative environment at Cytel Corporation, fostering advancements in immunotherapy.
Conclusion
Horacio Serra's contributions to ex vivo therapy and his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the field of immunotherapy and improve patient outcomes.